Emface simultaneously emits both synchronized radio frequency and HIFES-brand energies.

BTL is taking on the minimally invasive facial aesthetic category with the launch of EMFACE.

Emface simultaneously emits both synchronized radio frequency and HIFES-brand energies. The homogenous radiofrequency heats collagen and elastin fibers while the HIFES stimulation emits thousands of pulses per session to contract delicate facial muscles. 

The recommended treatment course for the EMFACE therapy calls for four 20-minute sessions, with each session completed 2-14 days apart.

The findings from 9 clinical studies concluded that participants who completed the recommended treatment course experienced, on average, a 37% reduction in wrinkles, 30% increase in facial muscle tone, and 23% lifting effect – with optimal results seen 6-12 weeks after final treatment. What's more, the 2-in-1 procedure is needle- and injectable-free and requires no pre- or post-preparation or downtime.

"When the innovative Emsculpt surprised the aesthetics market in 2018, BTL committed to continued investment in creating an extensive pipeline of groundbreaking therapies. Utilizing 20+ years of institutional knowledge we continue to round out the body solutions with our Emsculpt Neo platform and have our sights set on tackling facial applications with the Emface platform," says Scott Mills, President of BTL, in a news release.

"Emface is going to do for the face what Emsculpt did for the body," adds New York City facial plastic surgeon Yael Halaas, MD. "EMFACE helps restore more youthful function to facial muscles," 

Beverly Hills, CA-based plastic surgeon Brian Kinney, MD elaborates, "and it promotes more youthful-looking skin, which doesn't just look better, it functions more like it used to. It's very easy to explain this to people and they love the concepts, especially if they're averse to more invasive treatments or injectables, which many people are."